| scholarly article | Q13442814 |
| P2093 | author name string | Werner Tjarks | |
| Robert J Lee | |||
| Rolf F Barth | |||
| Gong Wu | |||
| Xiaogang Pan | |||
| Weiliang Yang | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates | Q34168201 | ||
| Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function | Q34328543 | ||
| Boron neutron capture therapy of cancer: current status and future prospects | Q34423179 | ||
| Convection-enhanced delivery of macromolecules in the brain | Q35091232 | ||
| A critical assessment of boron neutron capture therapy: an overview | Q35128580 | ||
| Ligand-targeted liposomal anticancer drugs | Q35157616 | ||
| Patterns of epidermal growth factor receptor amplification in malignant gliomas | Q35773514 | ||
| Current methods for attaching targeting ligands to liposomes and nanoparticles | Q35827433 | ||
| Tumour-selective drug delivery via folate receptor-targeted liposomes | Q36316608 | ||
| Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy | Q36418042 | ||
| Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy | Q38345789 | ||
| Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes | Q39594820 | ||
| Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. | Q40315666 | ||
| Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. | Q40465335 | ||
| Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent | Q40489766 | ||
| Targeting liposomes to tumor endothelial cells for neutron capture therapy | Q40526171 | ||
| Targeting of skeletal muscle in vitro using biotinylated immunoliposomes | Q40630563 | ||
| Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy | Q40691117 | ||
| Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas | Q41054436 | ||
| Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro | Q41125485 | ||
| EGFR gene amplification--rearrangement in human glioblastomas | Q41325100 | ||
| Immunoliposomes for Cancer Treatment | Q41526933 | ||
| Endocytosis and intracellular fate of liposomes using pyranine as a probe | Q41733914 | ||
| Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. | Q43785244 | ||
| Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy | Q43992743 | ||
| Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. | Q44010453 | ||
| Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents | Q44066292 | ||
| Peptide-targeted PEG-liposomes in anti-angiogenic therapy | Q44341764 | ||
| Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. | Q44480735 | ||
| Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. | Q45958600 | ||
| Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy | Q46843007 | ||
| Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether. | Q46885903 | ||
| Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. | Q51694740 | ||
| Immunoliposome targeting to CD4+ cells in human blood | Q68888653 | ||
| Cell-specific drug transfer from liposomes bearing monoclonal antibodies | Q70919769 | ||
| Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis | Q72237818 | ||
| A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs | Q73203628 | ||
| In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach | Q74256478 | ||
| P433 | issue | 1 | |
| P921 | main subject | cetuximab | Q420296 |
| P304 | page(s) | 101-108 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Bioconjugate Chemistry | Q2343023 |
| P1476 | title | Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. | |
| P478 | volume | 18 |
| Q44638571 | AFM phase imaging of soft-hydrated samples: a versatile tool to complete the chemical-physical study of liposomes |
| Q38887307 | Antibody-targeted nanoparticles for cancer treatment |
| Q36161132 | Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery |
| Q38040432 | Boron as a platform for new drug design |
| Q89141802 | Boron delivery agents for neutron capture therapy of cancer |
| Q38101626 | Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective |
| Q39144008 | COSAN as a molecular imaging platform: synthesis and "in vivo" imaging |
| Q38227494 | Cancer active targeting by nanoparticles: a comprehensive review of literature. |
| Q38768447 | Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells |
| Q55261866 | Chemical Reactive Anchoring Lipids with Different Performance for Cell Surface Re-engineering Application. |
| Q39741000 | Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential |
| Q21203116 | Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer |
| Q42364445 | Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody |
| Q58615055 | Development of Albumin-closo -Dodecaborate Conjugates as Boron Carriers for Neutron-Capture Therapy by Ru(bpy)3 -Photocatalyzed Modification of Tyrosine |
| Q48107797 | EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. |
| Q42174160 | Effects of doxorubicin-encapsulating AG73 peptide-modified liposomes on tumor selectivity and cytotoxicity |
| Q55195605 | Enhanced Antitumor Effects of Epidermal Growth Factor Receptor Targetable Cetuximab-Conjugated Polymeric Micelles for Photodynamic Therapy. |
| Q38938407 | EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer. |
| Q33704280 | Immunoliposomal systems targeting primary effusion lymphoma: in vitro study |
| Q37960529 | Improving the transport of chemotherapeutic drugs across the blood-brain barrier |
| Q48408217 | Liposomal boron delivery for neutron capture therapy |
| Q37640027 | Liposome surface functionalization based on different anchoring lipids via Staudinger ligation |
| Q37783973 | Methods for the Functionalisation of Nanoparticles: New Insights and Perspectives |
| Q38451910 | Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment |
| Q34089324 | Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy |
| Q50046023 | Preparation of Immunoliposomes by Direct Coupling of Antibodies Based on a Thioether Bond. |
| Q40076575 | Radiolabeled lipid nanoparticles for diagnostic imaging |
| Q38768444 | Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells |
| Q39915400 | Receptor-specific targeting with liposomes in vitro based on sterol-PEG(1300) anchors |
| Q39144516 | Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo |
| Q38960391 | Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy |
| Q37795605 | Strategies for the intracellular delivery of nanoparticles |
| Q36713632 | Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes |
| Q58615182 | Synthesis of oligo-closo-dodecaborates by Hüisgen click reaction as encapsulated agents for the preparation of high-boron-content liposomes for neutron capture therapy |
| Q34441852 | Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation |
| Q50232609 | Targeted imaging of EGFR overexpressed cancer cells by brightly fluorescent nanoparticles conjugated with cetuximab |
| Q26860103 | Targeting cancer using cholesterol conjugates |
| Q49829267 | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases |
| Q44625993 | Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy |
| Q35578037 | Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer |
Search more.